| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Arjun Jj Desai is Director at TLSI and has filed Form 4s across 2 companies. Arjun Jj Desai's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $924K at current prices.
The biggest single holding is TLSI (~$860K) as Director. The TLSI filings lean toward selling, a net 30,000 shares.
Arjun Jj Desai has 19 Form 4 filings on record from August 2023 to August 2026, across 3 companies: Director at Longeveron (LGVN), 2026; Director at Clene (CLNN), 2023–2026; Director at TriSalus Life Sciences (TLSI), 2023–2025.
The 22 reported transactions were 18 option or other derivative awards, 2 stock awards, 1 open-market sale and 1 disposition back to the company.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $111K.
The only open-market sale was 30,000 shares of TLSI at an average $3.69 on December 10, 2024, about $111K. Twelve months later TLSI was up 88%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | TLSI Trisalus Life Sciences, Inc. | Director | Sell | 30,000 | $3.69 | $110,700.00 | -10.8% | +21.0% | +88.3% |